Home / Resource Library / Safety and efficacy of PD-1 and PD-L1 inhibitors in relapsed and refractory Hodgkin’s lymphoma: a systematic review and meta-analysis of 20 prospective studies

Safety and efficacy of PD-1 and PD-L1 inhibitors in relapsed and refractory Hodgkin’s lymphoma: a systematic review and meta-analysis of 20 prospective studies

Membership Organisation

Healthcare Professional

Affected by Lymphoma

Researcher or Advocate

Safety and efficacy of PD-1 and PD-L1 inhibitors in relapsed and refractory Hodgkin’s lymphoma: a systematic review and meta-analysis of 20 prospective studies